337 related articles for article (PubMed ID: 36132858)
41. In vitro-in vivo correlation in nanocarriers: From protein corona to therapeutic implications.
Agnihotri TG; Alexander A; Agrawal M; Dubey SK; Jain A
J Control Release; 2023 Feb; 354():794-809. PubMed ID: 36709923
[TBL] [Abstract][Full Text] [Related]
42. Cancer Nano-Immunotherapy from the Injection to the Target: The Role of Protein Corona.
Mikelez-Alonso I; Aires A; Cortajarena AL
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947622
[TBL] [Abstract][Full Text] [Related]
43. Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences.
Foroozandeh P; Aziz AA
Nanoscale Res Lett; 2015; 10():221. PubMed ID: 25995715
[TBL] [Abstract][Full Text] [Related]
44. Iron Oxide Nanoparticle Coatings Dictate Cell Outcomes Despite the Influence of Protein Coronas.
Portilla Y; Mellid S; Paradela A; Ramos-Fernández A; Daviu N; Sanz-Ortega L; Pérez-Yagüe S; Morales MP; Barber DF
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7924-7944. PubMed ID: 33587585
[TBL] [Abstract][Full Text] [Related]
45. Recent advances in the analysis of nanoparticle-protein coronas.
Ovais M; Nethi SK; Ullah S; Ahmad I; Mukherjee S; Chen C
Nanomedicine (Lond); 2020 Apr; 15(10):1037-1061. PubMed ID: 32248745
[TBL] [Abstract][Full Text] [Related]
46. Nanomedicine delivery: does protein corona route to the target or off road?
Maiolo D; Del Pino P; Metrangolo P; Parak WJ; Baldelli Bombelli F
Nanomedicine (Lond); 2015; 10(21):3231-47. PubMed ID: 26470748
[TBL] [Abstract][Full Text] [Related]
47. Protein-gold nanoparticle interactions and their possible impact on biomedical applications.
Liu J; Peng Q
Acta Biomater; 2017 Jun; 55():13-27. PubMed ID: 28377307
[TBL] [Abstract][Full Text] [Related]
48. Biological Behavior Regulation of Gold Nanoparticles via the Protein Corona.
Ma Y; Hong J; Ding Y
Adv Healthc Mater; 2020 Mar; 9(6):e1901448. PubMed ID: 32080976
[TBL] [Abstract][Full Text] [Related]
49. Revising Protein Corona Characterization and Combining ITC and Nano-DSC to Understand the Interaction of Proteins With Porous Nanoparticles.
Balmori A; Sandu R; Gheorghe D; Botea-Petcu A; Precupas A; Tanasescu S; Sánchez-García D; Borrós S
Front Bioeng Biotechnol; 2021; 9():650281. PubMed ID: 34708023
[TBL] [Abstract][Full Text] [Related]
50. Analysing the nanoparticle-protein corona for potential molecular target identification.
Elechalawar CK; Hossen MN; McNally L; Bhattacharya R; Mukherjee P
J Control Release; 2020 Jun; 322():122-136. PubMed ID: 32165239
[TBL] [Abstract][Full Text] [Related]
51. The influence of protein corona on Graphene Oxide: implications for biomedical theranostics.
Quagliarini E; Pozzi D; Cardarelli F; Caracciolo G
J Nanobiotechnology; 2023 Aug; 21(1):267. PubMed ID: 37568181
[TBL] [Abstract][Full Text] [Related]
52. Protein Corona: Impact of Lymph Versus Blood in a Complex In Vitro Environment.
Bonvin D; Aschauer U; Alexander DTL; Chiappe D; Moniatte M; Hofmann H; Mionić Ebersold M
Small; 2017 Aug; 13(29):. PubMed ID: 28582610
[TBL] [Abstract][Full Text] [Related]
53. Gold nanoparticle should understand protein corona for being a clinical nanomaterial.
Charbgoo F; Nejabat M; Abnous K; Soltani F; Taghdisi SM; Alibolandi M; Thomas Shier W; Steele TWJ; Ramezani M
J Control Release; 2018 Feb; 272():39-53. PubMed ID: 29305922
[TBL] [Abstract][Full Text] [Related]
54. Nanoparticle protein corona evolution: from biological impact to biomarker discovery.
Kamaly N; Farokhzad OC; Corbo C
Nanoscale; 2022 Feb; 14(5):1606-1620. PubMed ID: 35076049
[TBL] [Abstract][Full Text] [Related]
55. Protein corona, understanding the nanoparticle-protein interactions and future perspectives: A critical review.
Kopac T
Int J Biol Macromol; 2021 Feb; 169():290-301. PubMed ID: 33340622
[TBL] [Abstract][Full Text] [Related]
56. Uptake of Upconverting Nanoparticles by Breast Cancer Cells: Surface Coating versus the Protein Corona.
Voronovic E; Skripka A; Jarockyte G; Ger M; Kuciauskas D; Kaupinis A; Valius M; Rotomskis R; Vetrone F; Karabanovas V
ACS Appl Mater Interfaces; 2021 Aug; 13(33):39076-39087. PubMed ID: 34378375
[TBL] [Abstract][Full Text] [Related]
57. Potential clinical applications of the personalized, disease-specific protein corona on nanoparticles.
García Vence M; Chantada-Vázquez MDP; Vázquez-Estévez S; Manuel Cameselle-Teijeiro J; Bravo SB; Núñez C
Clin Chim Acta; 2020 Feb; 501():102-111. PubMed ID: 31678275
[TBL] [Abstract][Full Text] [Related]
58. Nano-Cell Interactions of Non-Cationic Bionanomaterials.
Ho LWC; Liu Y; Han R; Bai Q; Choi CHJ
Acc Chem Res; 2019 Jun; 52(6):1519-1530. PubMed ID: 31058496
[TBL] [Abstract][Full Text] [Related]
59. Protein corona affects the relaxivity and MRI contrast efficiency of magnetic nanoparticles.
Amiri H; Bordonali L; Lascialfari A; Wan S; Monopoli MP; Lynch I; Laurent S; Mahmoudi M
Nanoscale; 2013 Sep; 5(18):8656-65. PubMed ID: 23896964
[TBL] [Abstract][Full Text] [Related]
60. Mapping the heterogeneity of protein corona by ex vivo magnetic levitation.
Ashkarran AA; Dararatana N; Crespy D; Caracciolo G; Mahmoudi M
Nanoscale; 2020 Jan; 12(4):2374-2383. PubMed ID: 31960871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
